Coronavirus Update: Will Moderna Really Demand Premium Price For COVID Vaccine?

Plus: Partners Launch Stem Cell Therapy Trial

 
• By Scrip Team

There are reports that the US biotech is considering pricing its as-yet-unapproved mRNA-1273 at $25-30 a dose, a price which would double as both a prime and boost dose would be administered.

Foodbank_NY
Food bank queue in New York: The economic effects of the pandemic have plunged millions into poverty in the US and globally • Source: Shutterstock

More from COVID-19

More from Scrip